1. A cost–utility analysis of dulaglutide versus insulin glargine as third-line therapy for Type 2 diabetes in Canada. (15th January 2019) Authors: Pollock, Richard F; Norrbacka, Kirsi; Cameron, Chris; Mancillas-Adame, Leonardo; Jeddi, Mark Journal: Journal of comparative effectiveness research Issue: Volume 8:Number 4(2019) Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. GLP-1 RA Treatment Patterns Among Type 2 Diabetes Patients in Five European Countries. Issue 1 (February 2017) Authors: Divino, Victoria; DeKoven, Mitch; Khan, Farhad; Boye, Kristina; Sapin, Hélène; Norrbacka, Kirsi Journal: Diabetes therapy Issue: Volume 8:Issue 1(2017) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Patient preferences and health state utilities associated with dulaglutide and semaglutide injection devices among patients with type 2 diabetes in Italy. (3rd August 2019) Authors: Boye, Kristina S.; Matza, Louis S.; Stewart, Katie D.; Jordan, Jessica; Biricolti, Giovanni; Del Santo, Silvia; Perez-Nieves, Magaly; Federici, Marco O.; Gentilella, Raffaella; Losi, Serena; Norrbacka, Kirsi Journal: Journal of medical economics Issue: Volume 22:Number 8(2019) Page Start: 806 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The cost-effectiveness of dulaglutide versus liraglutide for the treatment of type 2 diabetes mellitus in Spain in patients with BMI ≥30 kg/m2. (4th May 2017) Authors: Dilla, Tatiana; Alexiou, Dimitra; Chatzitheofilou, Ismini; Ayyub, Ruba; Lowin, Julia; Norrbacka, Kirsi Journal: Journal of medical economics Issue: Volume 20:Number 5(2017) Page Start: 443 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The cost-effectiveness of exenatide once weekly compared with exenatide twice daily and insulin glargine for the treatment of patients with type two diabetes and body mass index ≥30 kg/m2 in Spain. (July 2013) Authors: Fonseca, Tiago; Clegg, John; Caputo, Giuseppe; Norrbacka, Kirsi; Dilla, Tatiana; Alvarez, Maria Journal: Journal of medical economics Issue: Volume 16:Number 7(2013) Page Start: 926 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The PRIME Type 2 Diabetes Model: a novel, patient-level model for estimating long-term clinical and cost outcomes in patients with type 2 diabetes mellitus. (31st December 2022) Authors: Pollock, Richard F.; Norrbacka, Kirsi; Boye, Kristina S.; Osumili, Beatrice; Valentine, William J. Journal: Journal of medical economics Issue: Volume 25:Number 1(2022) Page Start: 393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The PRIME Type 2 Diabetes Model: a novel, patient-level model for estimating long-term clinical and cost outcomes in patients with type 2 diabetes mellitus. (31st December 2022) Authors: Pollock, Richard F.; Norrbacka, Kirsi; Boye, Kristina S.; Osumili, Beatrice; Valentine, William J. Journal: Journal of medical economics Issue: Volume 25:Number 1(2022) Page Start: 393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The PRIME Type 2 Diabetes Model: a novel, patient-level model for estimating long-term clinical and cost outcomes in patients with type 2 diabetes mellitus. (31st December 2022) Authors: Pollock, Richard F.; Norrbacka, Kirsi; Boye, Kristina S.; Osumili, Beatrice; Valentine, William J. Journal: Journal of medical economics Issue: Volume 25:Number 1(2022) Page Start: 393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Utilization patterns of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus in Germany: a retrospective cohort study. (4th May 2019) Authors: Otto, Thorsten; Myland, Melissa; Jung, Heike; Lebrec, Jeremie; Richter, Hartmut; Norrbacka, Kirsi Journal: Current medical research and opinion Issue: Volume 35:Number 5(2019) Page Start: 893 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗